Blackbird Critical Metals announces that it has entered into a definitive share purchase agreement, dated August 13, 2025 with Lir Life Sciences, a party at arm's length to the Company, pursuant to which it has agreed to acquire 100% of the issued and outstanding common shares in the capital of Lir Life Sciences in consideration for the issuance of at least 21,807,143 common shares in the capital of the Company, on a
[...]